FDA Approved: ZYRTEC-D — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

The FDA approves a supplemental application for ZYRTEC-D (cetirizine hydrochloride and pseudoephedrine hydrochloride) from Kenvue Brands LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• ZYRTEC-D (cetirizine hydrochloride and pseudoephedrine hydrochloride)

Snippet

SUPPL AP for ZYRTEC-D (CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE)